Found 6117 clinical trials
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Children and Adolescents >6 to
The main purpose of this study is to learn whether the study drug, rimegepant, is well tolerated and safe for the prevention of migraine compared to placebo in children and adolescents between the ages of 6 and 17 years. Enrollment starts with the 12 to 17 year old group. The …
- 0 views
- 19 Jan, 2023
- 1 location
A Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy, Safety and Tolerability of ABBV-951 to Oral Carbidopa/Levodopa in Advanced Parkinson's Disease Patients
The purpose of this study is to find out how well ABBV-951 works to control Parkinson's disease symptoms compared to oral Carbidopa (CD)/Levodopa (LD). The study is also seeking to test whether ABBV-951 is well tolerated in subjects with Parkinson's disease.
- 132 views
- 23 Nov, 2020
- 1 location
Evaluate the Efficacy and Safety of a Single Injection to the Target Knee
The study treatment consists of a single injection into the knee joint of your target knee.
- 161 views
- 23 Nov, 2020
- 1 location
Clinical Study to Assess the Efficacy and Safety of Tildrakizumab in the Treatment of Moderate to Severe Nail Psoriasis.
This study is for adults, 18 or older with a clinical diagnosis of chronic moderate to severe plaque-type psoriasis that has been present for at least 6 months. Subjects must also have moderate to severe psoriasis of the nails at the screening and baseline visits and who are considered candidates …
- 3 views
- 04 May, 2022
- 1 location
A Phase 2 Study to Investigate the Safety and Efficacy of ABBV-105 and Upadacitinib Given Alone or in Combination (ABBV-599 Combination) in Subjects with Moderately to Severely Active Systemic Lupus Erythematosus
The purpose of this study is to see if the study drugs, ABBV-105, upadacitinib (ABT-494), or both ABBV-105 and upadacitinib (ABT-494) in combination (ABBV-599) are safe, tolerable, and effective in treating your moderately to severely active systemic lupus erythematosus (SLE).
- 158 views
- 23 Nov, 2020
- 1 location
The purpose of this study is to compare the safety and effects, good or bad, of MSTT1041A versus placebo on patients with moderate to severe atopic dermatitis.
The purpose of this study is to compare the safety and effects, good or bad, of MSTT1041A versus placebo on patients with moderate to severe atopic dermatitis.
- 143 views
- 23 Nov, 2020
- 1 location
Add on treatment for COPD for patients who experience frequent exacerbations
Current or former smokers who are diagnosed with COPD and experienced at least 2 exacerbations- worsening of symptoms requiring steroid treatment or hospitalization despite being on multiple inhaler medications may qualify for this study involving benralizumab subcutaneous injections compared to placebo injections, initially every 4 weeks, then every 8 weeks …
- 0 views
- 09 Jun, 2022
- 1 location
ECOSPOR IV: An Open-Label Extension of Study SERES-012 and Open-Label Program for Evaluating SER-109 in Adult Subjects with Recurrent Clostridioides difficile Infection (RCDI)
ECOSPOR IV is a Phase 3, multicenter, Open Label study to evaluate the safety and tolerability of SER-109 in adult subjects with recurrent CDI.
- 77 views
- 21 Dec, 2020
- 77 locations
A research study for patients with cystic fibrosis who might have a condition called Fibrosing Colonopathy (FC).
A research study for patients with cystic fibrosis who might have a condition called Fibrosing Colonopathy (FC).
- 588 views
- 07 Nov, 2020
- 1 location
Clinical Study to Assess the Efficacy of a Topical Acne Product
Validated Claim Support (VCS) is searching for individuals 18 years and older who suffer from mild to moderate acne, to test acne products and get paid for your opinion and time. All subjects must have current visible active acne blemishes and will be fairly compensated. Please Note: Requirements are study …
- 0 views
- 02 Sep, 2022
- 1 location